Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 23
Encontrada(s) 1 página(s)

Docta Complutense
Publicación Artículo científico (JournalArticle)

Synthesis and Biophysical and Biological Studies of N-Phenylbenzamide Derivatives Targeting Kinetoplastid Parasites

  • Nué-Martinez, J.J.
  • Cisneros, David
  • Moreno-Blázquez, María del Valle
  • Fonseca-Berzal, Cristina
  • Manzano, J.I
  • Kraeutler, D
  • Ungogo, M.A
  • Aloraini, M.A
  • Elati, H.A.A
  • Ibáñez Escribano, Alexandra
  • Lagartera, L
  • Herraiz, Tomás
  • Gamarro, Francisco
  • de Koning, Harry P
  • Gómez-Barrio, Alicia
  • Dardonville, Christophe
The AT-rich mitochondrial DNA (kDNA) of trypanosomatid parasites is a target of DNA minor groove binders. We report the synthesis, antiprotozoal screening, and SAR studies of three series of analogues of the known antiprotozoal kDNA binder 2-((4-(4-((4,5-dihydro-1H-imidazol-3-ium-2-yl)amino)benzamido)phenyl)amino)-4,5-dihydro-1H-imidazol-3-ium (1a). Bis(2-aminoimidazolines) (1) and bis(2-aminobenzimidazoles) (2) showed micromolar range activity against Trypanosoma brucei, whereas bisarylimidamides (3) were submicromolar inhibitors of T. brucei, Trypanosoma cruzi, and Leishmania donovani. None of the compounds showed relevant activity against the urogenital, nonkinetoplastid parasite Trichomonas vaginalis. We show that series 1 and 3 bind strongly and selectively to the minor groove of AT DNA, whereas series 2 also binds by intercalation. The measured pKa indicated different ionization states at pH 7.4, which correlated with the DNA binding affinities (ΔTm) for series 2 and 3. Compound 3a, which was active and selective against the three parasites and displayed adequate metabolic stability, is a fine candidate for in vivo studies.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Thiol-ene "click" synthesis and pharmacological evaluation of c-glycoside sp2-iminosugar glycolipids

  • Sánchez-Fernández, Elena M.
  • García-Moreno, M. Isabel
  • García-Hernández, Raquel
  • Padrón, José M.
  • García Fernández, José Manuel
  • Gamarro, Francisco
  • Ortiz Mellet, Carmen
The unique stereoelectronic properties of sp2-iminosugars enable their participation in glycosylation reactions, thereby behaving as true carbohydrate chemical mimics. Among sp2-iminosugar conjugates, the sp2-iminosugar glycolipids (sp2-IGLs) have shown a variety of interesting pharmacological properties ranging from glycosidase inhibition to antiproliferative, antiparasitic, and anti-inflammatory activities. Developing strategies compatible with molecular diversity-oriented strategies for structure–activity relationship studies was therefore highly wanted. Here we show that a reaction sequence consisting in stereoselective C-allylation followed by thiol-ene “click” coupling provides a very convenient access to α-C-glycoside sp2-IGLs. Both the glycone moiety and the aglycone tail can be modified by using sp2-iminosugar precursors with different configurational profiles (d-gluco or d-galacto in this work) and varied thiols, as well as by oxidation of the sulfide adducts (to the corresponding sulfones in this work). A series of derivatives was prepared in this manner and their glycosidase inhibitory, antiproliferative and antileishmanial activities were evaluated in different settings. The results confirm that the inhibition of glycosidases, particularly α-glucosidase, and the antitumor/leishmanicidal activities are unrelated. The data are also consistent with the two later activities arising from the ability of the sp2-IGLs to interfere in the immune system response in a cell line and cell context dependent manner., This study was supported by the Spanish Ministerio de Economía y Competitividad (contract numbers RTI2018-093940-B-I00 and SAF2016-76083-R), the Spanish Ministerio de Ciencia, Innovación y Universidades (RTI2018-097210-B-I00 to FG), the European Regional Development Funds (FEDER and FSE). J.M.P. thanks the Spanish Government for financial support through project PGC2018-094503-B-C22 (MCIU/AEI/FEDER, UE)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

In vitro assessment of 3-alkoxy-5-nitroindazole-derived ethylamines and related compounds as potential antileishmanial drugs

  • Martín-Montes, Á.
  • Aguilera-Venegas, Benjamín
  • Morales-Martín, Rosa Mª
  • Martín-Escolano, R.
  • Zamora-Ledesma, S.
  • Marín, C.
  • Arán, Vicente J.
  • Sánchez-Moreno, Manuel
Leishmaniasis is a widespread neglected tropical disease complex that is responsible of one million new cases per year. Current treatments are outdated and pose many problems that new drugs need to overcome. With the goal of developing new, safe, and affordable drugs, we have studied the in vitro activity of 12 different 5-nitroindazole derivatives that showed previous activity against different strains of Trypanosoma cruzi in a previous work. T. cruzi belongs to the same family as Leishmania spp., and treatments for the disease it produces also needs renewal. Among the derivatives tested, compounds 1, 2, 9, 10, 11, and 12 showed low J774.2 macrophage toxicity, while their effect against both intracellular and extracellular forms of the studied parasites was higher than the ones found for the reference drug Meglumine Antimoniate (Glucantime®). In addition, their Fe-SOD inhibitory effect, the infection rates, metabolite alteration, and mitochondrial membrane potential of the parasites treated with the selected drugs were studied in order to gain insights into the action mechanism, and the results of these tests were more promising than those found with glucantime, as the leishmanicidal effect of these new drug candidates was higher. The promising results are encouraging to test these derivatives in more complex studies, such as in vivo studies and other experiments that could find out the exact mechanism of action., Authors appreciate the financial support from the Spanish Ministry of Science, Innovation and Universities (projects SAF2015-66690-R and RTI2018-093940-B-I00) and Spanish Ministry of Education and Science (project CSD 2010-00065). R.M.E. is grateful for a FPU grant [FPU14/01537] from the Ministry of Education of Spain and B.A.V. is grateful for an initiation into research grant from FONDECYT 11150559, Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Antimalarial quinoline drugs inhibit β-hematin and increase free hemin catalyzing peroxidative reactions and inhibition of cysteine proteases

  • Herraiz Tomico, Tomás
  • Guillén Fuerte, Hugo
  • González Peña, Diana
  • Arán, Vicente J.
Malaria caused by Plasmodium affects millions people worldwide. Plasmodium consumes hemoglobin during its intraerythrocytic stage leaving toxic heme. Parasite detoxifies free heme through formation of hemozoin (β-hematin) pigment. Proteolysis of hemoglobin and formation of hemozoin are two main targets for antimalarial drugs. Quinoline antimarial drugs and analogs (β-carbolines or nitroindazoles) were studied as inhibitors of β-hematin formation. The most potent inhibitors were quinacrine, chloroquine, and amodiaquine followed by quinidine, mefloquine and quinine whereas 8-hydroxyquinoline and β-carbolines had no effect. Compounds that inhibited β-hematin increased free hemin that promoted peroxidative reactions as determined with TMB and ABTS substrates. Hemin-catalyzed peroxidative reactions were potentiated in presence of proteins (i.e. globin or BSA) while antioxidants and peroxidase inhibitors decreased peroxidation. Free hemin increased by chloroquine action promoted oxidative reactions resulting in inhibition of proteolysis by three cysteine proteases: papain, ficin and cathepsin B. Glutathione reversed inhibition of proteolysis. These results show that active quinolines inhibit hemozoin and increase free hemin which in presence of HO that abounds in parasite digestive vacuole catalyzes peroxidative reactions and inhibition of cysteine proteases. This work suggests a link between the action of quinoline drugs with biochemical processes of peroxidation and inhibition of proteolysis., The authors thank Spanish Government-FEDER through projects RTI2018-093940-B-I00, RTI2018-095544-B-I00 and SAF-2015-66690-R. EY and FV are recipients of “Garantía Juvenil” fellowships from Comunidad de Madrid (Fondo Social Europeo-Iniciativa de Empleo Juvenil).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Discovery and pharmacological studies of 4-hydroxyphenyl-derived phosphonium salts active in a mouse model of visceral Leishmaniasis

  • Manzano, José Ignacio
  • Cueto-Díaz, Eduardo J.
  • Olías-Molero, Ana Isabel
  • Perea Martínez, Ana
  • Herraiz Tomico, Tomás
  • Torrado, Juan J.
  • Alunda, José María
  • Gamarro, Francisco
  • Dardonville, Christophe
We report the discovery of new 4-hydroxyphenyl phosphonium salt derivatives active in the submicromolar range (EC from 0.04 to 0.28 μM, SI > 10) against the protozoan parasite Leishmania donovani. The pharmacokinetics and in vivo oral efficacy of compound 1 [(16-(2,4-dihydroxyphenyl)-16-oxohexadecyl)triphenylphosphonium bromide] in a mouse model of visceral leishmaniasis were established. Compound 1 reduced the parasite load in spleen (98.9%) and liver (95.3%) of infected mice after an oral dosage of four daily doses of 1.5 mg/kg. Mode of action studies showed that compound 1 diffuses across the plasma membrane, as designed, and targets the mitochondrion of Leishmania parasites. Disruption of the energetic metabolism, with a decrease of intracellular ATP levels as well as mitochondrial depolarization together with a significant reactive oxygen species production, contributes to the leishmanicidal effect of 1. Importantly, this compound was equally effective against antimonials and miltefosine-resistant clinical isolates of Leishmania infantum, indicating its potential as antileishmanial lead., Funding from the Spanish Ministerio de Economia y Competitividad (grant SAF2015-66690-R) and the Spanish Ministerio de Ciencia, Innovacion y Universidades (MCIU/AEI/FEDER, UE; grants RTI2018-093940-B-I00 to C.D. and RTI2018-097210-B-I00 to F.G.).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A theoretical and spectroscopic (NMR and IR) study of indirubin in solution and in the solid state

  • Alkorta, Ibon
  • Elguero, José
  • Dardonville, Christophe
  • Reviriego, Felipe
  • Santa María, D.
  • Claramunt, Rosa M.
  • Marín-Luna, Marta
The infrared spectrum of indirubin in the solid state and the H, C and N NMR spectra in DMSO-d solution as well as the C and N CPMAS spectra have been recorded. Different types of calculations (B3LYP, GIAO, and GIPAW) have been carried out. Experimental and calculated values were compared yielding commensurate results. E/Z isomerism was explored, as was oxo/hydroxy tautomerism., Ministerio de Ciencia e Innovación, Grant/Award Numbers: PGC2018‐094644‐ B‐C22 and RTI2018‐093940‐B‐I00; Universidad Nacional de Educacion a Distancia (UNED); Comunidad de Madrid, Grant/Award Number: P2018/ EMT‐4329 AIRTEC‐CM; Ministerio de Ciencia, Innovación y Universidades, Grant/Award Numbers: RTI2018‐093940‐ B‐I00 and PGC2018‐094644‐B‐C22
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Activity profile of two 5-nitroindazole derivatives over the moderately drug-resistant Trypanosoma cruzi Y strain (DTU TcII): in vitro and in vivo studies

  • Fonseca-Berzal, Cristina
  • da Silva, C. F.
  • Batista, D. d. G. J.
  • de Oliveira, G. M.
  • Cumella, José
  • Batista, M. M.
  • Peres, R. B.
  • Silva da Gama Nefertiti, A.
  • Escario, José Antonio
  • Gómez-Barrio, Alicia
  • Arán, Vicente J.
  • Soeiro, M. d. N. C.
In previous studies, we have identified several families of 5-nitroindazole derivatives as promising antichagasic prototypes. Among them, 1-(2-aminoethyl)-2-benzyl-5-nitro-1,2-dihydro-3H-indazol-3-one, (hydrochloride) and 1-(2-acetoxyethyl)-2-benzyl-5-nitro-1,2-dihydro-3H-indazol-3-one (compounds 16 and 24, respectively) have recently shown outstanding activity in vitro over the drug-sensitive Trypanosoma cruzi CL strain (DTU TcVI). Here, we explored the activity of these derivatives against the moderately drug-resistant Y strain (DTU TcII), in vitro and in vivo. The outcomes confirmed their activity over replicative forms, showing IC50 values of 0.49 (16) and 5.75 μm (24) towards epimastigotes, 0.41 (16) and 1.17 μm (24) against intracellular amastigotes. These results, supported by the lack of toxicity on cardiac cells, led to better selectivities than benznidazole (BZ). Otherwise, they were not as active as BZ in vitro against the non-replicative form of the parasite, i.e. bloodstream trypomastigotes. In vivo, acute toxicity assays revealed the absence of toxic events when administered to mice. Moreover, different therapeutic schemes pointed to their capability for decreasing the parasitaemia of T. cruzi Y acute infected mice, reaching up to 60% of reduction at the peak day as monotherapy (16), 79.24 and 91.11% when 16 and 24 were co-administered with BZ. These combined therapies had also a positive impact over the mortality, yielding survivals of 83.33 and 66.67%, respectively, while untreated animals reached a cumulative mortality of 100%. These findings confirm the 5-nitroindazole scaffold as a putative prototype for developing novel drugs potentially applicable to the treatment of Chagas disease and introduce their suitability to act in combination with the reference drug., This work was supported by the Spanish Ministry of Economy, Industry and Competitiveness(MINEICO,ref.SAF2015-66690-R), the National Council for Scientific and Technological Development of Brazil (CNPq, ref. 301372/2015-2) and Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ,ref. E02/2017). The 911120 UCM-CEI Moncloa Research Group‘Epidemiología, Diagnóstico y Terapia Antiparasitaria’and the Spanish Ministry of Science, Innovation and Universities (MICIU, ref.RTI-2018-093940-B-I00) are also acknowledged. M.N.C.S. is a research fellowof CNPq and CNE researcher.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Synthesis, biological, and photophysical studies of molecular rotorbased fluorescent inhibitors of the trypanosome alternative oxidase

  • Cueto-Díaz, Eduardo J.
  • Ebiloma, Godwin U.
  • Alfayez, Ibrahim A.
  • Ungogo, Marzuq A.
  • Lemgruber, Leandro
  • González-García, Carmen
  • Giron, Maria D.
  • Salto, Rafael
  • Fueyo-González, Francisco
  • Shiba, Tomoo
  • González-Vera, Juan A.
  • Ruedas Rama, Maria José
  • de Koning, Harry P.
  • Dardonville, Christophe
We have recently reported on the development and trypanocidal activity of a class of inhibitors of Trypanosome Alternative Oxidase (TAO) that are targeted to the mitochondrial matrix by coupling to lipophilic cations via C14 linkers to enable optimal interaction with the enzyme’s active site. This strategy resulted in a much-enhanced anti-parasite effect, which we ascribed to the greater accumulation of the compound at the location of the target protein, i.e. the mitochondrion, but to date this localization has not been formally established. We therefore synthesized a series of fluorescent analogues to visualize accumulation and distribution within the cell. The fluorophore chosen, julolidine, has the remarkable extra feature of being able to function as a viscosity sensor and might thus additionally act as a probe of the cellular glycerol that is expected to be produced when TAO is inhibited. Two series of fluorescent inhibitor conjugates incorporating a cationic julolidine-based viscosity sensor were synthesized and their photophysical and biological properties were studied. These probes display a red emission, with a high signal-to-noise ratio (SNR), using both single- and two-photon excitation. Upon incubation with T. brucei and mammalian cells, the fluorescent inhibitors 1a and 2a were taken up selectively in the mitochondria as shown by live-cell imaging. Efficient partition of 1a in functional isolated (rat liver) mitochondria was estimated to 66 ± 20% of the total. The compounds inhibited recombinant TAO enzyme in the submicromolar (1a, 2c, 2d) to low nanomolar range (2a) and were effective against WT and multidrug-resistant trypanosome strains (B48, AQP1-3 KO) in the submicromolar range. Good selectivity (SI > 29) over mammalian HEK cells was observed. However, no viscosity-related shift could be detected, presumably because the glycerol was produced cytosolically, and released through aquaglyceroporins, whereas the probe was located, virtually exclusively, in the trypanosome’s mitochondrion., This work was supported by the Spanish Ministerio de Economia y Competitividad (grant SAF2015-66690-R), the Spanish Ministerio de Ciencia, Innovación y Universidades (MCIU/AEI/FEDER, UE; grants RTI2018-093940-B-I00 to CD, and CTQ2017-85658-R toAO) and the Japan Society for the promotion of Science (JSPS grant- 17F17420 to GUE). MAU is funded through a studentship from the Petroleum Technology Development Fund (PTDF), Abuja, Nigeria. IAA was funded through a Ph.D. studentship from the Ministry of Health of Saudi Arabia.We thank Dr. José Cumella for the synthesis of the 1,14-dibromotetradecane precursor and to Prof. Ibon Alkorta for his help with DFT calculations. We also thank Professor Fred Opperdoes and Dr Alena Zíkova for their insightful discussions on T. brucei energy metabolism., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Contribución de congreso (ConferenceOutput)

Solving a chemical challenge in the synthesis of antiprotozoal agents targeting the DNA minor groove: A high yield synthesis of trans-azoxybenzene

  • Nué Martínez, J. Jonathan
  • Alkorta, Ibon
  • Dardonville, Christophe
As part of our research program on the synthesis of new DNA minor groove binders ac8ve against kinetoplas8d parasites (i.e. T. brucei, T. cruzi, and L. donovani), we needed to prepare 2-isopropoxy-4- nitrobenzoic acid (1). A previously reported synthe8c approach consis8ng in the reac8on of 2-hydroxy-4- nitrobenzoic acid with an excess of 2-iodopropane had been reported earlier. The di-alkylated isopropyl 2- isopropoxy-4-nitrobenzoate intermediate (2), was then saponified using harsh basic condi8ons (i.e. 45% aqueous NaOH in THF/EtOH at 80 °C) to yield pure 1 (72% overall) by acid workup according to the reported procedure. However, our efforts to obtain 1 following this protocol were unsuccessful. In its place, (Z)-1,2-bis(4-carboxy- 3-isopropoxyphenyl)diazene-1-oxide deriva8ve (3) was isolated as main product (92%) of the reac8on. Full characteriza8on this trans-azoxybenzene deriva8ve was carried out by means of IR, 1H, 13C, and 15N NMR spectroscopy. Adjus8ng the internal temperature of the saponifica8on step was key to control the outcome of the reac8on towards the forma8on of either products 1 or 3. We show that working at room temperature and using lithium hydroxide instead of concentrate NaOH is an excellent alterna8ve to achieve the synthesis of the desired 2-isopropoxy-4-nitrobenzoic acid (1). On the other hand, working at high temperature (80 °C, as reported previously) is an excellent method for the high-yield synthesis of trans-azoxybenzene., This research was funded by Ministerio de Ciencia, Innovación y Universidades (MCIU/AEI/FEDER, UE), grant RTI2018-093940-B-I00.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Occurrence, formation from D‑fructose and 3‑deoxyglucosone, and activity of the carbohydrate-derived β‑carbolines in foods

  • Herraiz Tomico, Tomás
  • Vera, Fernando
β-Carbolines are naturally occurring bioactive alkaloids. In this work, carbohydrate-derived β-carbolines (βCs), 1-(1,3,4,5-tetrahydroxypent-1-yl)-β-carboline isomers (1a/b), 1-(1,4,5-trihydroxypent-1-yl)-β-carboline (2), 1-(1,5-dihydroxypent-3-en-1-yl)-β-carboline (3), and 1-(1,2,3,4,5-pentahydroxypent-1-yl)-β-carboline (4) were identified and analyzed in commercial foods. The concentrations of βCs 1–4 in foods ranged from undetectable to 11.4 μg/g levels, suggesting their intake in the diet. Processed foods contained higher amounts than fresh or unprocessed foods, and the highest content was found in processed tomato and fruit products, sauces, and baked foods. βCs 1–3 were formed in foods during heating, and 1a/b were the main compounds. The formation of carbohydrate-derived βCs was studied in model reactions of tryptophan and carbohydrates. They formed in reactions of tryptophan with glucose under acidic conditions at temperatures higher than 80 °C. The formation of 1a/b was favored, but 2–3 increased at high temperatures. Noticeably, the βCs 1–3 formed in the reactions of tryptophan with fructose or sucrose, and the formation from fructose was much higher than from glucose. Thus, fructose was the main carbohydrate involved in the formation of 1–3, whereas sucrose gave these βCs after acid hydrolysis. It is shown for the first time that the mechanism of formation of βCs 1–3 occurs from the sugar intermediate 3-deoxyglucosone that reacts with tryptophan affording these carbohydrate-derived βCs. A mechanism of reaction to give βCs 1–3 is proposed that relies on the tautomerism (keto–enediol or enamine–imine) of intermediates involved in the reaction. Carbohydrate βCs 1–4 were assessed as inhibitors of monoamine oxidase (MAO), as antioxidants, and for their interaction with DNA. They were not good inhibitors of MAO-A or -B, were poor antioxidants, and did not appreciably interact with DNA., The authors thank Spanish Government-Feder (projects RTI2018-093940-B-I00 and RTI2018-095544-B-I00) and project 200470E658 (CSIC). F.V. thanks Comunidad de Madrid (CAM) and Fondo Social Europeo (EU)-Iniciativa de Empleo Juvenil for a Garantia Juvenil contract. The authors thank Dr. Vicente Arán for his help in the discussion, and Haroll Mateo Felix for his technical assistance. H.M.F. is a recipient of a Garantia Juvenil contract from Comunidad de Madrid (Fondo Social Europeo-Iniciativa de Empleo Juvenil)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Imidazoline- and Benzamidine-Based Trypanosome Alternative Oxidase Inhibitors: Synthesis and Structure-Activity Relationship Studies

  • Cisneros, David
  • Cueto-Díaz, Eduardo J.
  • Medina-Gil, T.
  • Chevillard, R.
  • Bernal-Fraile, T.
  • López-Sastre, R.
  • Aldfer, M. M.
  • Ungogo, M. A.
  • Elati, H. A. A.
  • Arai, N.
  • Otani, M.
  • Matsushiro, S.
  • Kojima, C.
  • Ebiloma, Godwin U.
  • Shiba, T.
  • De Koning, H. P.
  • Dardonville, Christophe
The trypanosome alternative oxidase (TAO), a mitochondrial enzyme involved in the respiration of the bloodstream form trypomastigotes of Trypanosoma brucei, is a validated drug target against African trypanosomes. Earlier series of TAO inhibitors having a 2,4-dihydroxy-6-methylbenzoic acid scaffold ("head") and a triphenylphosphonium or quinolin-1-ium cation as a mitochondrion-targeting group ("tail") were shown to be nanomolar inhibitors in enzymatic and cellular assays. We investigated here the effect of different mitochondrion-targeting cations and other scaffold modifications on the in vitro activity of this class of inhibitors. Low micromolar range activities were obtained, and the structure-activity relationship studies showed that modulation of the tail region with polar substituents is generally detrimental to the enzymatic and cellular activity of TAO inhibitors., This work was funded by Ministerio de Ciencia, Innovació n/ Agencia Estatal de Investigació n (MCIN/AEI/10.13039/ 501100011033), through the project RTI2018-093940-B-I00 (co-funded by European Regional Development Fund, ERDF, “A way to build Europe”). This research was also supported by a fellowship grant from the Japan Society for the promotion of Science (JSPS Grant No. 17F17420) to G.U.E. M.M.A. and H.A.A.E. were funded by studentships from the Libyan government. M.A.U. was funded by the Petroleum Technology Development Fund of Nigeria
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

5-Nitroindazole-based compounds: further studies for activity optimization as anti-Trypanosoma cruzi agents

  • Fonseca-Berzal, Cristina
  • Ibáñez-Escribano, Alexandra
  • Castro, Sonia de
  • Escario, José Antonio
  • Gómez-Barrio, Alicia
  • Arán, Vicente J.
In this study, a new series of eleven 5-nitroindazole derivatives (10−20) and a related 6-nitroquinazoline (21) was synthesized and tested in vitro against different forms of the kinetoplastid parasite Trypanosoma cruzi, etiological agent of Chagas disease. Among these compounds, derivatives 11−14 and 17 showed trypanocidal profiles on epimastigotes (IC50 = 1.00−8.75 µM) considerably better than that of the reference drug benznidazole, BZ (IC50 = 25.22 µM). Furthermore, the lack of cytotoxicity observed for compounds 11, 12, 14, 17 and 18 over L929 fibroblasts, led to a notable selectivity (SI) on the extracellular replicative form of the parasite: SIEPI > 12.41 to > 256 µM. Since these five derivatives overpassed the cut-off value established by BZ (SIEPI ≥ 10), they were moved to a more specific assay against the intracellular and replicative form of T. cruzi, i.e, amastigotes. These molecules were not as active as BZ (IC50 = 0.57 µM) against this parasite form; however, all of them showed remarkable IC50 values lower than 7 µM. Special mention deserve compounds 12 and 17, whose SIAMA were > 246.15 and > 188.23, respectively. The results compiled in the present work, point to a positive impact over the trypanocidal activity of the electron withdrawing substituents introduced at position 2 of the N-2 benzyl moiety of these compounds, especially fluorine, i.e., derivatives 12 and 17. These outcomes, supported by the in silico prediction of good oral bioavailability and suitable risk profile, reinforce the 5-nitroindazole scaffold as an adequate template for preparing potential antichagasic agents., This work was partially supported by the Spanish Ministry of Econ- omy, Industry and Competitiveness (MINEICO, ref. SAF2015-66690-R) and the 911120 UCM Research Group “Epidemiología, Diagnóstico y Terapia Antiparasitaria”. The Spanish Ministry of Science, Innovation and Universities (MICIU, ref. RTI2018-093940-B-I00) is also acknowledged, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Formation, characterization, and occurrence of β-carboline alkaloids derived from α-dicarbonyl compounds and l -tryptophan

  • Herraiz Tomico, Tomás
  • Peña, Adriana
  • Mateo, Haroll
  • Herraiz Carasa, Marta
  • Salgado, Antonio
β-Carbolines (βCs) are naturally occurring bioactive alkaloids, whereas α-dicarbonyl compounds are reactive substances generated in foods and in vivo. In this work, l-tryptophan reacted with α-dicarbonyl compounds affording new β-carbolines. Glyoxal afforded 1-hydroxymethyl-β-carboline (HME-βC) and its 3-carboxylic acid, and methylglyoxal afforded 1-(1-hydroxyethyl)-β-carboline (HET-βC) and its 3-carboxylic acid. 3-Deoxyglucosone afforded 1-(1,3,4,5-tetrahydroxypent-1-yl)-β-carboline isomers (1a/b), 1-(1,4,5-trihydroxypent-1-yl)-β-carboline (2), and 1-(1,5-dihydroxypent-3-en-1-yl)-β-carboline (3). The formation of these βCs increased under acidic conditions and with increasing temperature. A mechanism is proposed explaining the conversion of a carbonyl into a hydroxy group based on tautomerism and cyclization to the dihydro-βC-3-COOH intermediates, which were isolated and gave the βCs. These α-dicarbonyl-derived βCs occurred in model reactions of l-tryptophan with fructose or glucose incubated under heating and can be considered as advanced glycation end products (AGEs). They were also present in foods and formed during heating processes. HET-βC appeared in processed foods, reaching up to 309 ng/g, with the highest amount found in dried tomato, fried onion, toasted bread, and Manuka honey. HME-βC was only detected in some foods with lower amounts than HET-βC. HET-βC appeared in foods as a racemic mixture of enantiomers suggesting the same mechanism of formation as the synthetized product. α-Dicarbonyl-derived βCs (HET-βC, HME-βC, and 1a/b-3) occur in foods and food processing and, therefore, they are ingested during diet., The authors thank the Spanish Government-Feder (projects RTI2018-093940-B-I00 and RTI2018-095544-B-I00) and CSIC for financial support. H.M. and A.P. thank Consejería de Ciencia, Universidades e Innovación de la Comunidad de Madrid (CM) and the “Fondo Social Europeo-Iniciativa de Empleo Juvenil (YEI)” for Garantia Juvenil contracts., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

β-carboline alkaloids in soy sauce and inhibition of monoamine oxidase (MAO)

  • Herraiz Tomico, Tomás
Monoamine oxidase (MAO) oxidizes neurotransmitters and xenobiotic amines, including vasopressor and neurotoxic amines such as the MPTP neurotoxin. Its inhibitors are useful as antidepressants and neuroprotectants. This work shows that diluted soy sauce (1/3) and soy sauce extracts inhibited human MAO-A and -B isozymes in vitro, which were measured with a chromatographic assay to avoid interferences, and it suggests the presence of MAO inhibitors. Chromatographic and spectrometric studies showed the occurrence of the β-carboline alkaloids harman and norharman in soy sauce extracts inhibiting MAO-A. Harman was isolated from soy sauce, and it was a potent and competitive inhibitor of MAO-A (0.4 µM, 44 % inhibition). The concentrations of harman and norharman were determined in commercial soy sauces, reaching 243 and 52 μg/L, respectively. Subsequently, the alkaloids 1,2,3,4-tetrahydro-β-carboline-3-carboxylic acid (THCA) and 1-methyl-1,2,3,4-tetrahydro-β-carboline-3-carboxylic acid (MTCA) were identified and analyzed in soy sauces reaching concentrations of 69 and 448 mg/L, respectively. The results show that MTCA was a precursor of harman under oxidative and heating conditions, and soy sauces increased the amount of harman under those conditions. This work shows that soy sauce contains bioactive β-carbolines and constitutes a dietary source of MAO-A and -B inhibitors., The author thanks CSIC (project 200470E658), and RTI2018-093940-B-100, RTI2018-095544-B-100 and PID2021-1278330B-100 funded by MCIN/AEI /10.13039/501100011033 and ERDF A way of making Europe., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Synthesis and biophysical and biological studies of N-phenylbenzamide derivatives targeting kinetoplastid parasites

  • Nué Martínez, J. Jonathan
  • Cisneros, David
  • Moreno-Blázquez, María del Valle
  • Fonseca-Berzal, Cristina
  • Manzano, José Ignacio
  • Kraeutler, Damien
  • Ungogo, Marzuq A.
  • Aloraini, Maha A.
  • Elati, Hamza A. A.
  • Ibáñez-Escribano, Alexandra
  • Lagartera, Laura
  • Herraiz Tomico, Tomás
  • Gamarro, Francisco
  • Koning, Harry P. de
  • Gómez-Barrio, Alicia
  • Dardonville, Christophe
The AT-rich mitochondrial DNA (kDNA) of trypanosomatid parasites is a target of DNA minor groove binders. We report the synthesis, antiprotozoal screening, and SAR studies of three series of analogues of the known antiprotozoal kDNA binder 2-((4-(4-((4,5-dihydro-1H-imidazol-3-ium-2-yl)amino)benzamido)phenyl)amino)-4,5-dihydro-1H-imidazol-3-ium (1a). Bis(2-aminoimidazolines) (1) and bis(2-aminobenzimidazoles) (2) showed micromolar range activity against Trypanosoma brucei, whereas bisarylimidamides (3) were submicromolar inhibitors of T. brucei, Trypanosoma cruzi, and Leishmania donovani. None of the compounds showed relevant activity against the urogenital, nonkinetoplastid parasite Trichomonas vaginalis. We show that series 1 and 3 bind strongly and selectively to the minor groove of AT DNA, whereas series 2 also binds by intercalation. The measured pKa indicated different ionization states at pH 7.4, which correlated with the DNA binding affinities (ΔTm) for series 2 and 3. Compound 3a, which was active and selective against the three parasites and displayed adequate metabolic stability, is a fine candidate for in vivo studies., This study was funded by Agencia Estatal de Investigación (MCIN/AEI/10.13039/501100011033) through the projects RTI2018–093940–B-I00 (C.D.) and RTI2018–097210–B–I00 (F.G.) (Co-funded by the European Regional Development Fund. ERDF, “A way to build Europe”), and PDC2022–133269-I00 (funded by the Recovery and Resilience Facility, RRF, NextGenerationEU). M.A.U. was funded by a studentship from the Petroleum Technology Development Fund, Abuja, Nigeria. H.A.A.E. is supported by a PhD studentship from the Libyan Government and M.A.A. by a PhD studentship from the Saudi Arabian Ministry of Education., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Otros (Other)

Assay of MAO inhibition by chromatographic techniques (HPLC/HPLC-MS)

  • Herraiz Tomico, Tomás
Monoamine oxidase (MAO) enzymes (MAO A and B) catalyze the oxidative deamination of biogenic amines, neurotransmitters, and xenobiotic amines and contribute to the regulation of the content of these active substances in mammalian organisms. The oxidation of biogenic amines by MAO produces hydrogen peroxide (H2O2) and aldehydes that represent risk factors for oxidative injury. The inhibitors of MAO are useful as antidepressants and neuroprotective agents. Usually, the assays of MAO determine amine deamination products or measure the H2O2 released by using direct spectrophotometric or fluorimetric methods. Direct methods are more prone to interferences and can afford inaccurate results. Those limitations can be avoided by using chromatographic techniques. This work describes a chromatographic method to assay MAO A and MAO B activity by using kynuramine as a nonselective substrate and the subsequent analysis of 4-hydroxyquinoline by RP-HPLC-DAD-fluorescence and mass spectrometry (MS). Alternatively, the assay uses the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxin as a substrate of MAO that is oxidized (bioactivated) to neurotoxic pyridinium cations which are analyzed by HPLC. These methods are applied to assess the inhibition of MAO by bioactive β-carboline alkaloids occurring in foods, plants, and biological systems., The author thank the Spanish Government-FEDER through projects RTI2018-093940-B-I00 and RTI2018-095544-B-I00., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Crystal structure of the HMGA AT-hook 1 domain bound to the minor groove of AT-rich DNA and inhibition by antikinetoplastid drugs

  • Nué Martínez, J. Jonathan
  • Maturana, M.
  • Lagartera, Laura
  • Rodríguez-Gutiérrez, J. A.
  • Boer, R.
  • Campos, J. L.
  • Saperas, N.
  • Dardonville, Christophe
High mobility group (HMG) proteins are intrinsically disordered nuclear non-histone chromosomal proteins that play an essential role in many biological processes by regulating the expression of numerous genes in eukaryote cells. HMGA proteins contain three DNA binding motifs, the “AT-hooks”, that bind preferentially to AT-rich sequences in the minor groove of B-form DNA. Understanding the interactions of AT-hook domains with DNA is very relevant from a medical point of view because HMGA proteins are involved in different conditions including cancer and parasitic diseases. We present here the first crystal structure (1.40 Å resolution) of the HMGA AT-hook 1 domain, bound to the minor groove of AT-rich DNA. In contrast to AT-hook 3 which bends DNA and shows a larger minor groove widening, AT-hook 1 binds neighbouring DNA molecules and displays moderate widening of DNA upon binding. The binding affinity and thermodynamics of binding were studied in solution with surface plasmon resonance (SPR)-biosensor and isothermal titration calorimetry (ITC) experiments. AT-hook 1 forms an entropy-driven 2:1 complex with (TTAA)-containing DNA with relatively slow kinetics of association/dissociation. We show that N-phenylbenzamide-derived antikinetoplastid compounds (1–3) bind strongly and specifically to the minor groove of AT-DNA and compete with AT-hook 1 for binding. The central core of the molecule is the basis for the observed sequence selectivity of these compounds. These findings provide clues regarding a possible mode of action of DNA minor groove binding compounds that are relevant to major neglected tropical diseases such as leishmaniasis and trypanosomiasis., This study was funded by Generalitat de Catalunya (Grant: 2021SGR-01042) and by Agencia Estatal de Inves- tigación (MCIN/AEI/10.13039/501100011033) and “ERDF A way of making Europe”, by the “European Un- ion”, through the grants RTI2018-093940-B-I00, PID2022-136438OB-I00, PID2022-140302OB-I00, and PD- C2022−133269-I00 (funded by the Recovery and Resilience Facility, RRF, NextGenerationEU). Open Access funding provided thanks to the CRUE-CSIC agreement with Springer Nature.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Nanostructured Lipid Carrier for Intracellular Delivery of a Bis(pyridine-2-carboxamidine) DNA Minor Groove Binder Active against Leishmania

  • Nué Martínez, J. Jonathan
  • Leo-Barriga, Marta
  • Herranz, Fernando
  • Koutsogiannis, Zisis
  • Denny, Paul W.
  • Ebiloma, Godwin U.
  • Dardonville, Christophe
  • González-Paredes, Ana
Two types of nanostructured lipid carrier (NLC) formulations of the antileishmanial DNA minor groove binding compound 4-(picolinimidamido)-N-(4-(picolinimidamido)phenyl)benzamide (1) were synthesized by the microemulsion method to evaluate their potential as a delivery system to intracellular forms of the Leishmania parasite. Compound 1-loaded NLC formulations, functionalized with folic acid (FA) or not, showed good colloidal stability both during storage and after dilution in biologically relevant media. The drug release, which was not pH dependent, occurred efficiently at 37 °C. Compound 1 and its NLC formulations displayed a good selectivity index (SI > 40) and were active in the submicromolar range against promastigotes and metacyclic promastigotes of Leishmania major and in the low micromolar range (∼2 μM) against intramacrophage amastigotes. However, they were inactive against Leishmania mexicana. This proof-of-concept study showed that compound 1 could be loaded effectively in NLC and FA-coated NLC whose size and anionic nature (i.e., FA-NLC) are favorable for uptake into macrophages. NLC functionalization with FA had a beneficial effect on the antileishmanial activity of 1 compared with noncoated NLC formulations, which resulted in an increase in selectivity toward the parasite., This study was supported by Agencia Estatal de Investigación (MCIN/AEI/10.13039/501100011033) and “ERDF A way of making Europe”, by the “European Union”, under grants RTI2018-093940-B-I00, PID2022-136438OB-I00, and PDC2022-133269-I00 (funded by the Recovery and Resilience Facility, RRF, NextGenerationEU) and Comunidad de Madrid (Spain) under “Atracción de Talento (Modalidad 1)” program (Reference 2019-T1/IND-12906)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Uncovering the Unusual Inhibition Mechanism of a Trypanosome Alternative Oxidase Inhibitor Displaying Broad-Spectrum Activity against African Animal Trypanosomes

  • Ebiloma, Godwin U.
  • Balogun, Emmanuel O.
  • Arai, Natsumi
  • Otani, Momoka
  • Baldassarri, Cecilia
  • Alhejely, Amani
  • Cueto-Díaz, Eduardo J.
  • De Koning, Harry P.
  • Dardonville, Christophe
  • Shiba, Tomoo
The glucose-dependent respiration of bloodstream forms of the parasite Trypanosoma brucei depends on an unusual and essential mitochondrial electron-transport system, consisting of glycerol-3-phosphate dehydrogenase and the trypanosome alternative oxidase (TAO). We report here the discovery of an allosteric inhibitor of TAO that displays highly potent activity (EC50 values in the range 1-20 nM) against the important veterinary pathogens T. b. brucei, Trypanosoma evansi, Trypanosoma equiperdum, and Trypanosoma congolense, i.e., >5-fold greater potency than the standard drugs. The methylene-linked 2-methyl-4-hydroxybenzoate 2-pyridinyldiphenylphosphonium derivative (1) was the best inhibitor of recombinant TAO (IC50 = 1.3 nM) via a noncompetitive/allosteric mechanism (Ki = 3.46 nM). Remarkably, X-ray crystallography showed that 1 was bound to a site of TAO ∼25 Å from the catalytic pocket. Although 1 demonstrated good safety toward mammalian cells in vitro (selectivity index >2300), it did not fully clear parasitemia in experimental animals, attributable to a high hepatic clearance., This study received funding from the Japan Society for the Promotion of Science (JSPS) through a JSPS postdoctoral fellowship research grant (17F17420), and a Royal Society Grant (RGS\R2\222269) to G.U.E. The research is also funded by Agencia Estatal de Investigación (MCIN/AEI/10.13039/ 501100011033), and “ERDF A way of making Europe”, by the “European Union”, through the grants RTI2018-093940-B-I00, PID2022-136438OB-I00, and PDC2022-133269-I00 (funded by the Recovery and Resilience Facility, RRF, NextGener- ationEU). E.O.B. is a recipient of an Emerging Global Leader (K43) Award and is supported by the Fogarty International Center of the National Institutes of Health under Award Number K43TW012015. The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health., Peer reviewed
Docta Complutense
Publicación Artículo científico (JournalArticle)

Promising hit compounds against resistant trichomoniasis: Synthesis and antiparasitic activity of 3-(ω-aminoalkoxy)-1-benzyl-5-nitroindazoles

  • Ibáñez Escribano, Alexandra
  • Reviriego, Felipe
  • Vela, Nerea
  • Fonseca Berzal, Cristina Rosa
  • Nogal Ruiz, Juan José
  • Arán, Vicente J.
  • Escario García-Trevijano, José Antonio
  • Gómez Barrio, Alicia
A series of 11 3-(ω-aminoalkoxy)-1-benzyl-5-nitroindazoles (2–12) has been prepared starting from 1-benzyl-5-nitroindazol-3-ol 13, and evaluated against sensitive and resistant isolates of the sexually transmitted protozoan Trichomonas vaginalis. Compounds 2, 3, 6, 9, 10 and 11 showed trichomonacidal profiles with IC50 < 20 µM against the metronidazole-sensitive isolate. Moreover, all these compounds submitted to cytotoxicity assays against mammalian cells exhibited low non-specific cytotoxic effects, except compounds 3 and 9 which displayed moderate cytotoxicity (CC50 = 74.7 and 59.1 µM, respectively). Those compounds with trichomonacidal effect were also evaluated against a metronidazole-resistant culture. Special mention deserve compounds 6 and 10, which displayed better IC50 values (1.3 and 0.5 µM respectively) than that of the reference drug (IC50 MTZ = 3.0 µM). The high activity of these compounds against the resistant isolate reinforces the absence of cross-resistance with the reference drug. The remarkable trichomonacidal results against resistant T. vaginalis isolates suggest the interest of 3-(ω-aminoalkoxy)-1-benzyl-5-nitroindazoles to be considered as good prototypes to continue in the development of new drugs with enhanced trichomonacidal activity, aiming to increase the non-existent drugs to face clinical resistance efficiently for those patients in whom therapy with 5-nitroimidazoles is contraindicated.
e_Buah Biblioteca Digital Universidad de Alcalá
Publicación Artículo científico (JournalArticle)

Study of different chitosan/sodium carboxymethyl cellulose proportions in the development of polyelectrolyte complexes for the sustained release of clarithromycin from matrix tablets

  • Guarnizo Herrero, Víctor|||0000-0001-9323-3388
  • Torrado Salmerón, Carlos Félix
  • Torres Pabón, Norma Sofía|||0000-0002-0028-0802
  • Torrado Durán, Guillermo|||0000-0002-8865-2083
  • Morales Valenzuela, Javier Eduardo
  • Torrado Santiago, Santiago
This study investigated the combination of different proportions of cationic chitosan and anionic carboxymethyl cellulose (CMC) for the development of polyelectrolyte complexes to be used as a carrier in a sustained-release system. Analysis via scanning electron microscopy (SEM) Fourier transform infrared spectroscopy (FTIR), differential scanning calorimetry (DSC), and powder X-ray diffraction (PXRD) confirmed ionic interactions occur between the chitosan and carboxymethyl cellulose chains, which increases drug entrapment. The results of the dissolution study in acetate buffer (pH 4.2) showed significant increases in the kinetic profiles of clarithromycin for low proportions of chitosan/carboxymethyl cellulose tablets, while the tablets containing only chitosan had high relaxation of chitosan chains and disintegrated rapidly. The Korsmeyer–Peppas kinetic model for the different interpolymer complexes demonstrated that the clarithromycin transport mechanism was controlled by Fickian diffusion. These results suggest that the matrix tablets with different proportions of chitosan/carboxymethyl cellulose enhanced the ionic interaction and enabled the prolonged release of clarithromycin., Agencia Estatal de Investigación
e_Buah Biblioteca Digital Universidad de Alcalá
Publicación Artículo científico (JournalArticle)

Self-micellizing technology improves the properties of ezetimibe and increases its effect on hyperlipidemic rats

  • Torrado Salmerón, Carlos Félix
  • Guarnizo Herrero, Víctor|||0000-0001-9323-3388
  • Cerezo Garreta, Javier
  • Torrado Durán, Guillermo|||0000-0002-8865-2083
  • Torrado Santiago, Santiago
The aim of this work was to develop ezetimibe self-micellizing solid dispersions using Kolliphor® RH40 (MS-K) as a surfactant incorporating ezetimibe (EZ) into the croscarmellose hydrophilic carrier. Different ezetimibe:Kolliphor® ratios were studied to select micellar systems that improve the dissolution properties of ezetimibe. The different formulations were characterized by means of solid state analysis by SEM, powder X-ray diffraction (PXRD), differential scanning calorimetry (DSC), and dissolution studies. These physicochemical studies showed a decrease from the crystalline structure of ezetimibe (EZ) to its amorphous state in the micellar systems (MS-K). A rapid dissolution profile was observed in these micellar systems compared to the drug raw material and physical mixture. Efficacy studies were conducted using a high-fat diet that induced hyperlipidemic rats. The micellar system selected (MS-K 1:0.75) revealed a significant improvement in serum levels of total cholesterol (TC), low-density lipoproteins (LDL), and triglycerides (TG) compared to ezetimibe raw material. The histopathological examination of liver tissue also showed that this micellar system exhibited more beneficial effects on liver steatosis compared to ezetimibe raw material (EZ-RM) and the high-fat diet group (HFD). This study suggests that EZ micellar systems using Kolliphor® RH40 could enhance the antihyperlipidemic effect of ezetimibe and reduce liver steatosis., Agencia Estatal de Investigación
e_Buah Biblioteca Digital Universidad de Alcalá
Publicación Artículo científico (JournalArticle)

Improvement in the oral bioavailability and efficacy of new ezetimibe formulations-comparative study of a solid dispersion and different micellar systems

  • Torrado Salmerón, Carlos Félix
  • Guarnizo Herrero, Víctor|||0000-0001-9323-3388
  • Gallego Arranz, Teresa
  • Val Sabugo, Yvonne del
  • Torrado Durán, Guillermo|||0000-0002-8865-2083
  • Morales Valenzuela, Javier Eduardo
  • Torrado Santiago, Santiago
Ezetimibe (EZ) is a poorly water-soluble drug with low bioavailability. Strategies such as solid dispersions (SD) and micellar systems (MS) were developed to identify the most effective drug delivery formulations with the highest oral bioavailability, and to improve their lipid-lowering effect. The EZ formulations were prepared with different proportions of Kolliphor® RH40 as a surfactant (1:0.25, 1:0.5 and 1:0.75) and croscarmellose as a hydrophilic carrier. These excipients, and the addition of microcrystalline cellulose during the production process, led to significant improvements in the dissolution profiles of MS. Powder X-ray diffraction (PXRD), differential scanning calorimetry (DSC) and scanning electron microscopy (SEM) revealed an amorphous form of ezetimibe with different semicrystalline states of microcrystalline cellulose for MS-I (1:0.75) and MS-II (1:0.75). Pharmacokinetic analysis after administration of MS-II (1:0.75) demonstrated a 173.86% increase in maximum plasma concentration (Cmax) and a 142.99% increase in oral bioavailability compared to EZ raw material (EZ-RM). Efficacy studies with the micellar system MS-II (1:0.75) in rats with hyperlipidemia showed that total cholesterol, triglycerides and high-density lipoprotein were reduced to normal levels and revealed improvements in low-density lipoprotein, aspartate and alanine aminotransferase. The improvement in the dissolution rate with micellar systems increases bioavailability and enhances the anti-hyperlipidemic effect of EZ., Agencia Estatal de Investigación